{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:31:45Z","timestamp":1744209105561},"reference-count":35,"publisher":"Japan Society of Histochemistry & Cytochemistry","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Histochemica et Cytochemica","Acta Histochem. Cytochem","Acta Histochem. Cytochem."],"published-print":{"date-parts":[[2019,2,28]]},"DOI":"10.1267\/ahc.18036","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T20:47:20Z","timestamp":1550868440000},"page":"27-34","source":"Crossref","is-referenced-by-count":6,"title":["Immunohistochemistry for Anti-diabetes Drug, Alogliptin Using a Newly Prepared Monoclonal Antibody: Its Precise Localization in Rat Small Intestine"],"prefix":"10.1267","volume":"52","author":[{"given":"Yuta","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Applied Life Science, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Applied Life Science, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Saita","sequence":"additional","affiliation":[{"name":"Department of Applied Life Science, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Applied Life Science, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"334","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bai, J. P. (1994) Distribution of brush-border membrane peptidases along the rat intestine. Pharm. Res. 11; 897\u2013900.","DOI":"10.1023\/A:1018946228432"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Christopher, R., Convingtone, P., Davenport, M., Fleck, P., Mekki, Q. A., Wann, E. R. and Karim, A. (2008) Pharmaco\u00adkinetics, pharmacodynamics, and tolerability of single increasing does of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects. Clin. Ther. 30; 513\u2013527.","DOI":"10.1016\/j.clinthera.2008.03.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Clancy, B. and Cauller, L. J. (1998) Reduction of background autofluorescence in brain sections following immersion in sodium borohydride. J. Neurosci. Methods 83; 97\u2013102.","DOI":"10.1016\/S0165-0270(98)00066-1"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Drucker, D. J. and Nauck, N. A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368; 1696\u20131705.","DOI":"10.1016\/S0140-6736(06)69705-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T. and Rosebraugh, C. (2014) Pancreatic safety of incretin-based drugs\u2014FDA and EMA assessment. N. Engl. J. Med. 370; 794\u2013797.","DOI":"10.1056\/NEJMp1314078"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Faillie, J. L., Azoulay, L., Patenaude, V., Hillaire-Buys, D. and Suissa, S. (2014) Incretine based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study. BMJ 348; g2780.","DOI":"10.1136\/bmj.g2780"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Finley, J. C., Grossman, G. H., Dimeo, P. and Petrusz, P. (1978) Somatostatin-containing neurons in the rat brain: widespread distribution revealed by immunocytochemistry after pretreatment with pronase. Am. J. Anat. 153; 483\u2013488.","DOI":"10.1002\/aja.1001530312"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Fothergill, L. J. and Furness, J. B. (2018) Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification scheme. Histochem. Cell Biol. 150; 693\u2013702.","DOI":"10.1007\/s00418-018-1746-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Fujiwara, K., Yasuno, M. and Kitagawa, T. (1981) Novel preparation method of immunogen for hydrophobic hapten, enzyme immunoassay for daunomycin and adriamycin. J. Immunol. Methods 45; 195\u2013203.","DOI":"10.1016\/0022-1759(81)90213-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Fujiwara, K. and Masuyama, Y. (1995) Monoclonal antibody against the glutaraldehyde-conjugated polyamine, spermine. Histochem. Cell Biol. 104; 309\u2013316.","DOI":"10.1007\/BF01464327"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Fujiwara, K., Shin, M., Hougaard, D. M. and Larsson. L. I. (2007) Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies. Histochem. Cell Biol. 127; 69\u201377.","DOI":"10.1007\/s00418-006-0216-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Fujiwara, K., Shin, M., Matsunaga, H., Saita, T. and Larsson, L. I. (2009) Light-microscopic immunocytochemistry for genta\u00admicin and its use for studying uptake of the drug in kidney. Antimicrob. Agents Chemother. 53; 3302\u20133307.","DOI":"10.1128\/AAC.01627-08"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Fujiwara, K., Shin, M., Miyazaki, T. and Maruta. Y. (2011) Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats. Antimicrob. Agents Chemother. 55; 62\u201371.","DOI":"10.1128\/AAC.01031-10"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Fujiwara, K., Yoshizaki, Y., Shin, M., Miyazaki, T., Saita, T. and Nagata, S. (2012) Immunocytchemistry for vancomycin using a monoclonal antibody that reveals accumulation of the drug in tat kidney and liver. Antimicrob. Agents Chemother. 56; 5883\u20135891.","DOI":"10.1128\/AAC.01267-12"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Fukasawa, K. M., Fukasawa, K., Sahara, N., Harada, M., Kondo, Y. and Nagatsu, I. (1981) Immunohistochemical localization of dipeptidyl aminopeptidase IV in rat kidney, liver, and salivary glands. J. Histochem. Cytochem. 29; 337\u2013343.","DOI":"10.1177\/29.3.6787113"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Greischel, A., Binder, R. and Baierl, J. (2010) The dipeptidyl peptidase-4 inhibitor linagliptin exhibits time- and dose-dependent localization in kidney, liver, and intestine after intravenous dosing: Results from high resolution auto\u00adradiography in rats. Drug Metab. Dispos. 38; 1443\u20131448.","DOI":"10.1124\/dmd.110.034199"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Haraguchi, C. M. and Yokota, S. (2002) Immunofluorescence technique for 100-nm-thick semithin sections of Epon-embedded tissues. Histochem. Cell Biol. 117; 81\u201385.","DOI":"10.1007\/s00418-001-0363-1"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Hartel, S., Gossrau, R., Hanski, C. and Reutter, W. (1988) Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and the activity histochemistry. Histochemistry 89; 151\u2013161.","DOI":"10.1007\/BF00489918"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kahn, S. E. (2013) Incretin therapy and islet pathology: A time for caution. Diabetes 62; 2178\u20132180.","DOI":"10.2337\/db13-0520"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Klein, T., Fujii, M., Sandel, J., Shibazaki, Y., Wakamatsu, K., Mark, M. and Yoneyama, H. (2014) Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis. Med. Mol. Morphol. 47; 137\u2013149.","DOI":"10.1007\/s00795-013-0053-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Lambeir, A. M., Durinx, C., Scharpe, S. and De Meester, I. (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 40; 209\u2013294.","DOI":"10.1080\/713609354"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Lee, B., Shi, L., Kassel, D. B., Asakawa, T., Takeuchi, K. and Christopher, R. J. (2008) Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys. Eur. J. Pharmacol. 589; 306\u2013314.","DOI":"10.1016\/j.ejphar.2008.04.047"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lee, C. F., Sun, M. S. and Tai, Y. K. (2014) Saxagliptin-induced recurrent acute pancreatitis. Intern. Med. 53; 1351\u20131354.","DOI":"10.2169\/internalmedicine.53.1913"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Mentlein, R. (1999) Dipepticyl-peptidase IV (CD26)\u2014role in the inactivation of regulatory peptides. Regul. Pept. 85; 9\u201324.","DOI":"10.1016\/S0167-0115(99)00089-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Mentzel, S., Dijkman, H. B., Van Son, J. P., Koene, R. A. and Assmann, K. J. (1996) Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J. Histochem. Cytochem. 1996; 445\u2013461.","DOI":"10.1177\/44.5.8627002"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Mest, H. J. and Mentlein, R. (2005) Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes. Diabetologia 48; 616\u2013620.","DOI":"10.1007\/s00125-005-1707-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Nagel, A. K., Ahmed-Sarwar, N., Werner, P. M., Cipriano, G. C., Van Manen, R. P. and Rrown, J. E. (2016) Dipeptidyl Peptidase-4 inhibitor-associated pancreatic carcinoma: A review of the FAERS database. Ann. Pharmacother. 50; 27\u201331.","DOI":"10.1177\/1060028015610123"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Nakamaru, Y., Akahoshi, F., Iiiima, H., Hisanaga, N. and Kume, T. (2016) Tissue distribution of teneligliptin in rats and comparisons with data reported for other dipeptidyl peptidase-4 inhibitors. Biopharm. Drug Dispos. 37; 142\u2013155.","DOI":"10.1002\/bdd.2003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Saisho, Y. (2015) Alogliptin benzoate for management of type 2 diabetes. Vasc. Health Risk Manag. 11; 229\u2013243.","DOI":"10.2147\/VHRM.S68564"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Scheen, A. J. (2010) Pharmacokinetics of dipeptidyl peptidase 4 inhibitors. Diabetes Obes. Metab. 12; 648\u2013658.","DOI":"10.1111\/j.1463-1326.2010.01212.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Scheen, A. J. (2015) Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes. Expert Opin. Drug Saf. 14; 505\u2013524.","DOI":"10.1517\/14740338.2015.1006625"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Shin, M., Larsson, L.-I., Hougaard, D. M. and Fujiwara, K. (2009) Daunomycin accumulation and induction of programmed cell death in rat hair follicles. Cell Tissue Res. 337; 429\u2013438.","DOI":"10.1007\/s00441-009-0840-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Suzuki, H., Yamada, K., Matsuda, Y., Onozuka, M. and Yamamoto, T. (2017) CXCL14-like immunoreactivity exists in somatostatin-containing endocrine cells, and in the lamina propria and submucosal somatostatinergic nervous system of mouse alimentary tract. Acta Histochem. Cytochem. 50; 149\u2013158.","DOI":"10.1267\/ahc.17015"},{"key":"34","unstructured":"34 Takeda Pharmaceuticals U.S.A., Inc. (2013) Nesina (alogliptin), prescribing information."},{"key":"35","unstructured":"35 WHO (2016) Global Report on Diabetes, World Health Organization, Geneva."}],"container-title":["ACTA HISTOCHEMICA ET CYTOCHEMICA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/52\/1\/52_18036\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T10:27:46Z","timestamp":1554114466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/52\/1\/52_18036\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1267\/ahc.18036","relation":{},"ISSN":["0044-5991","1347-5800"],"issn-type":[{"value":"0044-5991","type":"print"},{"value":"1347-5800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]}}}